Reed Elsevier NV Press Releases

ENL 
$44.32
*  
0.12
0.27%
Get ENL Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading ENL now
Exchange: NYSE
Industry: Consumer Services
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

ADDING MULTIMEDIA Reed Tech Strengthens Line of LexisNexis Intellectual Property Solutions by Acquiring PatentCore, an Innovator in Patent Data Analytics
7/8/2014 9:05:00 AM - Business Wire

Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA® buprenorphine in opioid-experienced patients with chronic pain
7/7/2014 7:00:00 AM - PR Newswire

Endo International plc Announces Pricing of Private Offering Of Senior Notes
6/25/2014 10:08:00 PM - PR Newswire

Endo International plc Announces Proposed Private Offering Of Senior Notes
6/25/2014 7:30:00 AM - PR Newswire

Elsevier Announces New Reference Module in Biomedical Sciences That Unlocks Current Foundational Content
6/25/2014 4:00:00 AM - Business Wire

Elsevier Chosen to Publish American Dental Association's Flagship Journal
6/24/2014 10:00:00 AM - PR Newswire

Endo to Acquire DAVA Pharmaceuticals
6/24/2014 9:10:00 AM - PR Newswire

Trendlines Acquires Intellectual Property from Collaboration with Endo
6/18/2014 8:00:00 AM - PR Newswire

American Medical Systems Enrolls First Patient in Embrace, a 522 Post Market Surveillance Study for the Elevate™ Anterior and Apical Prolapse System
6/9/2014 4:30:00 PM - PR Newswire

Endo Completes Sale of Early Stage Drug Discovery Portfolio
6/2/2014 7:30:00 AM - PR Newswire

LexisNexis Acquires Wunelli for Greater Telematics Insights, Speed to Market
5/20/2014 7:30:00 AM - Business Wire

Endo Completes Acquisition of Rights to Sumavel® DosePro®
5/19/2014 7:34:00 AM - PR Newswire

Endo Announces Appearances at Upcoming Conferences
5/9/2014 9:00:00 AM - PR Newswire

Endo Health Solutions Inc. Final Results and Settlement of Exchange Offers and Consent Solicitations Relating to its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022
5/6/2014 5:00:00 PM - PR Newswire

Endo Reports First Quarter Financial Results
5/1/2014 6:00:00 AM - PR Newswire

Endo Health Solutions Inc. Announces Extension of Expiration Date and Reopening of Withdrawal Rights in Exchange Offers for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022
4/30/2014 6:30:00 PM - PR Newswire

Endo Reaches Agreements in Principle to Settle a Substantial Majority of AMS Litigation Cases
4/30/2014 4:30:00 PM - PR Newswire

Endo Health Solutions Inc. Announces Extension of Expiration Date in Exchange Offers for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022
4/30/2014 8:00:00 AM - PR Newswire

Endo to Acquire Specialty Pharmaceuticals Company Somar
4/29/2014 8:30:00 AM - PR Newswire

Endo Appoints Dr. Hemanth J. Varghese as Executive Vice President of Corporate Development and Strategy
4/28/2014 4:30:00 PM - PR Newswire

Endo Acquires Rights to Sumavel® DosePro®
4/24/2014 7:30:00 AM - PR Newswire

Endo Health Solutions Inc. Announces Receipt of Requisite Tenders and Consents in the Exchange Offers and Consent Solicitations Relating to its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7¼% Senior Notes due 2022
4/17/2014 8:00:00 AM - PR Newswire

Endo to Announce First Quarter 2014 Financial Results on May 1, 2014
4/15/2014 4:00:00 PM - PR Newswire